Everwell Health announced the completion of an open-label consumer study on its beauty-from-within ingredient, Lustriva. The study evaluated the ingredient’s real-world impact on hair and skin appearance, as well as measures of consumers’ self-confidence.

In the study, 103 participants (90 female, 13 male) with medically-validated mild-to-moderate hair thinning tracked changes in their hair and skin appearance over 12 weeks while consuming Lustriva daily. Outcomes were measured using questionnaires at weeks 4, 8, and 12, including the validated hair loss quality of life survey.

Participants reported improvements in hair appearance, including:

• 70% reported reduced hair shedding
• 57% reported reduced hair thinning
• 48% reported an increase in new hair growth

The largest changes over the course of the study were the reduction of hair thinning, and an improvement in the shininess and overall appearance of hair.

When it came to skin improvements:

• 50% reported healthier-looking, smoother-feeling skin
• 40% reported brighter-looking skin
• 34% reported noticeable improvements in visible lines and wrinkles

The hair loss quality of life survey assessed the impact participants’ hair had on their overall quality of life. At the beginning of the study, just 17% sadi their hair had no impact on their quality of life, signifying that most felt affected by their hair’s appearance.

By the end of the study, 57% reported that their hair had no effect on their quality of life.

“This threefold increase reflects Lustriva’s ability to help reduce the negative impact of hair concerns on daily life. Importantly, participants’ self-confidence grew measurably over the duration of the study, with nearly 60% stating they felt more confident at the end of the 12 weeks, supporting the changes participants experienced were more than just cosmetic,” said Catherine Kwik-Uribe, chief science officer at Everwell Health.

The study was conducted with KGL Skin Study Center in Broomall, PA, an independent clinical research facility specializing in the efficacy of hair and skin products.

“What stands out to me are the results consumers themselves reported in this study, including a reduction in hair thinning, an increase in new hair growth, and improved satisfaction with the appearance of both hair and skin. These real-world data directly align with, and further add credibility to, the existing body of clinical evidence supporting Lustriva,” said Dr. Omer Ibrahim, board-certified dermatologist and medical director of KGL Skin Study Center. “Over the course of 12 weeks, consumers noticed improvements in nearly all self-reported hair and skin outcomes. Even more compelling are the results from the Hair Loss Quality of Life survey, which examines the effect hair loss has on daily life and confidence. These data show that Lustriva had a meaningful impact on increasing the proportion of those who said their hair no longer had a negative effect on their daily quality of life. For consumers who continue taking Lustriva long term, I would expect continued improvement in results, self-confidence, and overall satisfaction with their appearance.”

“As consumers increasingly embrace a more holistic approach to beauty, they prioritize products and ingredients backed by science,” said Kwik-Uribe. “Today’s consumers want benefits they can see and feel. This study demonstrated meaningful, consumer-perceived benefits and further strengthens Lustriva’s scientific foundation as an effective ingredient for promoting existing hair growth and healthier-looking skin.”